Vascular endothelial growth factor: a neurovascular target in neurological diseases

C Lange, E Storkebaum, CR De Almodóvar… - Nature Reviews …, 2016 - nature.com
Brain function critically relies on blood vessels to supply oxygen and nutrients, to establish a
barrier for neurotoxic substances, and to clear waste products. The archetypal vascular …

Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases

PA Campochiaro, A Akhlaq - Progress in retinal and eye research, 2021 - Elsevier
Neovascular age-related macular degeneration (NVAMD) is the most prevalent choroidal
vascular disease, and diabetic retinopathy (DR) and retinal vein occlusion (RVO) are the …

[HTML][HTML] Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction

JR Tribble, A Otmani, S Sun, SA Ellis, G Cimaglia… - Redox biology, 2021 - Elsevier
Nicotinamide adenine dinucleotide (NAD) is a REDOX cofactor and metabolite essential for
neuronal survival. Glaucoma is a common neurodegenerative disease in which neuronal …

Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non …

PM Lacal, G Graziani - Pharmacological research, 2018 - Elsevier
The vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine kinase receptor
for VEGF-A, VEGF-B, and placental growth factor (PlGF) ligands that is expressed in …

[HTML][HTML] Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography

J Chhablani, A Sharma, A Goud… - … & visual science, 2015 - jov.arvojournals.org
Purpose: The purpose of this study was to assess changes in the neural retina in eyes with
different stages of diabetic retinopathy (DR) in comparison to age-matched healthy subjects …

Neuroprotective factors of the retina and their role in promoting survival of retinal ganglion cells: a review

E Fudalej, M Justyniarska, K Kasarełło… - Ophthalmic …, 2021 - karger.com
Retinal ganglion cells (RGCs) play a crucial role in the visual pathway. As their axons form
the optic nerve, apoptosis of these cells causes neurodegenerative vision loss. RGC death …

Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead

R Boia, N Ruzafa, ID Aires, X Pereiro… - International journal of …, 2020 - mdpi.com
The retinal ganglion cells (RGCs) are the output cells of the retina into the brain. In
mammals, these cells are not able to regenerate their axons after optic nerve injury, leaving …

[HTML][HTML] Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under …

M Amadio, S Govoni, A Pascale - Pharmacological research, 2016 - Elsevier
Roughly ten years ago the FDA approved most of the presently used anti-VEGF drugs for the
treatment of neovascular AMD and other eye pathologies characterized by ocular …

Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy

J Li, K Chen, X Li, X Zhang, L Zhang, Q Yang… - Cell Death …, 2023 - nature.com
In the early stages of diabetic retinopathy (DR), diabetes-related hyperglycemia directly
inhibits the AKT signaling pathway by increasing oxidative stress or inhibiting growth factor …

VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons

N Froger, F Matonti, C Roubeix, V Forster, I Ivkovic… - Scientific reports, 2020 - nature.com
Vascular endothelial growth factor-A (VEGF) is the angiogenic factor promoting the
pathological neovascularization in age-related macular degeneration (AMD) or diabetic …